Literature DB >> 841682

Viability and function of platelets frozen at 2 to 3 C per minute with 4 or 5 per cent DMSO and stored at -80 C for 8 months.

J I Spector, J A Yarmala, L D Marchionni, C P Emerson, C R Valeri.   

Abstract

Each of 15 healthy male volunteers was treated with 650 mg of aspirin 24 hours before the autologous transfusion of one unit of freeze-preserved platelets. Freeze-thaw-wash recovery values in vitro, viability and function in vivo, and the bleeding time and platelet aggregation response were measured. The platelets were frozen with 4 or 5 per cent dimethylsulfoxide (DMSO) at an overall rate of 2 to 3 C per minute and were stored at -80 C in a mechanical freezer for up to eight months. They were washed by dilution/centrifugation. The mean recovery in vitro of platelets frozen with 4 per cent DMSO was 76+/-16%; the value was 64+/-16% for platelets frozen with 5% DMSO. The mean in vivo 51Cr recovery of autologous platelets frozen with 4% DMSO was 34+/-6%, and for platelets frozen with 5% DMSO it was 33+/-7%. In both groups the platelet lifespan was normal. There was a significant reduction in bleeding time after the transfusion of a single unit of autologous platelets preserved with either 4 or 5% DMSO, but no improvement in the aspirin-induced platelet aggregation pattern.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 841682     DOI: 10.1046/j.1537-2995.1977.17177128894.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide.

Authors:  J E Repine; J W Eaton; M W Anders; J R Hoidal; R B Fox
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

2.  The use of cryopreserved platelets in a trauma-induced hemorrhage model.

Authors:  Derek J B Kleinveld; Pieter H Sloos; Femke Noorman; M Adrie W Maas; Jesper Kers; Tim W H Rijnhout; Margreet Zoodsma; Rigo Hoencamp; Markus W Hollmann; Nicole P Juffermans
Journal:  Transfusion       Date:  2020-06-27       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.